Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Radioprotection encompasses all methods and agents that prevent or lessen the biological damage caused by ionizing radiation, including principles applied in occupational, environmental, and medical contexts[1][2][3][6][8]. In medicine, radioprotective agents are used mainly to reduce the adverse effects of radiotherapy in cancer patients[7]. At the molecular level, radioprotective drugs act by counteracting radiation-induced oxidative stress, maintaining antioxidant stores, and modulating inflammatory or stress pathways[7]. The field involves both non-pharmaceutical measures (such as shielding, minimizing exposure time, and maximizing distance from sources) and molecular agents such as antioxidants, cytokine modulators, and receptor agonists[1][5][7]. "Radioprotection" is not a molecular target but a multidisciplinary approach and collection of strategies for radiation safety[1][2][3][6][7][8].
Scavenging reactive oxygen species (ROS); Enhancement of cellular antioxidant capacity; Modulation of cytokine production/binding; Activation of pro-survival signaling pathways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Radioprotection.